China NMPA Drug Inspection - Hunan Huaxia Xiangzhong Pharmaceutical Pieces Co., Ltd. - Sodium valproate tablets
China NMPA drug inspection for Hunan Huaxia Xiangzhong Pharmaceutical Pieces Co., Ltd. published July 31, 2018. Drug: Sodium valproate tablets. The Shanghai Municipal Food and Drug Administration (SFDA) issued its 2018 Issue 7 Drug Supervision and Sampling Quality
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Hunan Huaxia Xiangzhong Pharmaceutical Pieces Co., Ltd. published July 31, 2018. Drug: Sodium valproate tablets. The Shanghai Municipal Food and Drug Administration (SFDA) issued its 2018 Issue 7 Drug Supervision and Sampling Quality
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox